FDA Inspection 746885 — Medefil Incorporated
The FDA completed an inspection of Medefil Incorporated on September 6, 2011 in Glendale Heights, IL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- September 6, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Glendale Heights, IL (United States)